12 Biggest Mid-Day Losers For Thursday By: Benzinga via Benzinga September 29, 2016 at 13:10 PM EDT Intra-Cellular Therapies Inc (NASDAQ: ITCI) shares tumbled 63.2 percent to $15.60 after its lead product candidate, ... Read More >> Related Stocks: Actinium Pharmaceuticals Inc Arcturus Therapeutics Holdings Inc Fitbit Inc Galectin Therapeutic Genocea Biosciences Intra-Cellular Ther Kona Grill Inc Marinus Pharma CS Shineco Inc Smartrent Inc